| Biotechnology Industry | Healthcare Sector | Mr. Stephen Patrick O'Hara CEO | LSE Exchange | GB00BP0RTP38 ISIN |
| United Kingdom Country | 10 Employees | - Last Dividend | - Last Split | - IPO Date |
OptiBiotix Health Plc is a UK-based life sciences company that operates on a global scale, including in the United States, China, and other international markets. Founded in 2006 and originally known as Ducat Ventures PLC until its name change in August 2014, the company specializes in the discovery and development of microbiome modulators. These are designed to interact beneficially with the human microbiome—the collection of all the microorganisms living in association with the human body—to improve health and wellbeing. OptiBiotix focuses on creating microbial strains, compounds, and formulations that can be integrated into food ingredients, supplements, and active compounds. These products aim to impact human physiology positively and provide potential health benefits, specifically targeting the prevention and management of chronic lifestyle disorders such as obesity, hypercholesterolemia, and diabetes. Headquartered in York, United Kingdom, OptiBiotix is at the forefront of leveraging microbiome science to bring innovative health solutions to the global market.
An innovative weight management system designed to help maintain a healthy weight in a hunger-free manner. Utilizing a scientifically formulated blend of ingredients, Slimbiome promotes feelings of fullness, helps control cravings, and supports metabolism for sustainable weight management.
A natural supplement aimed at supporting weight management. SlimBiome Medical uses a unique formulation to support dietary management efforts, facilitating easier and more manageable weight loss journeys for individuals seeking a natural approach.
A specially identified probiotic strain designed to aid cardiovascular health and overall wellbeing. Lactobacillus plantarum LPLDL can help manage cholesterol levels and promote heart health, demonstrating OptiBiotix's commitment to leveraging beneficial bacteria for physical health improvements.
A targeted food supplement designed for the reduction of cholesterol and blood pressure levels. CholBiome uses a synergistic blend of ingredients to support cardiovascular health, addressing some of the primary factors associated with heart disease.
A type of galactooligosaccharide used in various food products and applications. LPGOS is known for its prebiotic properties, supporting gut health, reducing cardiovascular risk factors, and enhancing overall health through improved digestive well-being.
A revolutionary low-calorie sweetener designed for use in food and beverages. Sweetbiotix offers the sweet taste consumers enjoy without the added calories, enabling healthier diet choices without sacrificing flavor, illustrating OptiBiotix's innovation in food ingredient development.